NIH-funded research R21 grant

Insomnia, Depression, and Sleep Medications in Mild Cognitive Impairment Leading to Dementia

Official title: Insomnia, Depression, and Medication Effects on Mild Cognitive Impairment to Dementia Progression: A Nationwide TriNetX Cohort Study

Funded at Saint Louis University · NIH-11438046 · Data updated 2026-11-12

This project looks at how sleep problems and depression, along with the medicines used to treat them, may affect the progression from mild cognitive issues to dementia in older adults.

More Dementia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionSaint Louis University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 15, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$423,500
NIH project number1R21AG104024-01
Project IDNIH-11438046 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 65 and older with mild cognitive impairment who are being treated for insomnia or major depressive disorder.

Less likely to help

Patients without MCI or those not on insomnia or antidepressant therapies may not experience direct benefits.

What this research studies

The study uses a nationwide patient cohort to explore how insomnia and major depressive disorder, separately and together, influence the transition from mild cognitive impairment to Alzheimer’s-related dementias. It will examine real-world prescribing patterns of insomnia and depression medications and how these might change the risk of progression. By leveraging electronic health records from a large network, researchers aim to identify modifiable factors that could delay dementia onset. The findings could help clinicians tailor treatment plans for older adults with MCI to potentially slow decline.

Why it matters

Potential benefit: If successful, the research could inform safer, more effective treatment choices for insomnia and depression to help delay dementia progression in older adults.

How similar studies have gone: Previous work has linked insomnia and depression to dementia risk, but their combined impact on MCI progression is less well understood.

Where this research is happening

  • Saint Louis University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Ahn, Sangnam — Saint Louis University
  • Study coordinator: Ahn, Sangnam

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.